THE INSTITUTE FOR CANCER RESEARCH
THE INSTITUTE FOR CANCER RESEARCH has won 12 federal awards worth $4.4M in total across 1 agencies, with a median award of $1.1M. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
12
awards won
$4.4M
total obligated
$1.1M
median award
1
agencies
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS | Department Of Health And Human Services | $1.0M | 2023-07-07 |
| PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND | Department Of Health And Human Services | $1.2M | 2023-05-01 |
| TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON | Department Of Health And Human Services | $702K | 2022-09-15 |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL | Department Of Health And Human Services | $614K | 2022-06-13 |
| THE ELNITSKI LAB IS PURCHASING NORMAL, LIVER, AND PROSTATE CANCER PATI | Department Of Health And Human Services | $17K | 2021-05-03 |
Agencies they win from
7 more awards + the price forecast for any solicitation this contractor is bidding.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.